Status:
COMPLETED
Y2Prevent: Preventing Drug Use and HIV Through Empowerment, Social Support and Mentorship (Y2P)
Lead Sponsor:
Children's Hospital Los Angeles
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
HIV
Drug Use
Eligibility:
MALE
18-24 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to pilot test a group level intervention, called Y2Prevent, which aims to decrease drug use and HIV/STI risk among Black/African American young men who have sex with...
Detailed Description
The overarching aim is to develop a culturally tailored and developmentally appropriate HIV prevention intervention for African American young men who have sex with men (AAYMSM), ages 18 to 24 years. ...
Eligibility Criteria
Inclusion
- 18-24 years old;
- identify as a cisgender male;
- identify as Black/African American;
- identify as gay, bisexual, or some other same-sex identity, and/or report having had sex with a man;
- HIV-negative;
- not currently enrolled in an HIV prevention study;
- living in the Los Angeles metro area;
- has access to a device (laptop, tablet or phone) with internet access in order to participate in virtual group sessions, complete online surveys, and receive payment via Venmo or Cash App; and
- has access to a telephone in order to be able to participate in and complete the qualitative exit interview, which will be conducted via telephone.
Exclusion
- outside age 18-24 years old;
- identify as a transgender man or woman;
- identify as White/Caucasian, Latino/Hispanic, Asian/Pacific Islander, Native American, Indigenous, or any other ethnicity besides African American;
- identify as straight;
- HIV-positive;
- currently enrolled in an HIV prevention study;
- currently living outside the Los Angeles metro area;
- does not have access to a device (laptop, tablet or phone) with internet access, which is necessary to participate in weekly group sessions, complete online surveys and receive payment for participation via Venmo or Cash App; and
- does not have access to a telephone, which is necessary to participate in the qualitative exit interview at the end of the seventh and final study session.
Key Trial Info
Start Date :
January 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04504981
Start Date
January 22 2020
End Date
March 1 2023
Last Update
July 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027